---
layout: default
title: Insulin Lispro
description: "Insulin Lispro çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 9 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 88
evidence_level: L5
indication_count: 9
---

# Insulin Lispro

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>9</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Insulin Lisproï¼šå¾ç³–å°¿ç—…åˆ° Autoimmune Oophoritis

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Insulin Lispro å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Insulin Lispro åŸæœ¬ç”¨æ–¼ç³–å°¿ç—…çš„è¡€ç³–æ§åˆ¶ã€‚
TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å° **Autoimmune Oophoritis** (è‡ªé«”å…ç–«æ€§åµå·¢ç‚) æœ‰æ•ˆï¼Œ
ä½†ç›®å‰ç¼ºä¹è‡¨åºŠè©¦é©—å’Œæ–‡ç»æ”¯æŒé€™å€‹æ–¹å‘ã€‚
</p>


## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | ç³–å°¿ç—…(æˆäººã€é’å°‘å¹´åŠ1æ­²ä»¥ä¸Šå…’ç«¥) |
| é æ¸¬æ–°é©æ‡‰ç—‡ | Autoimmune Oophoritis |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.78% |
| è­‰æ“šç­‰ç´š | L5 |
| å°ç£ä¸Šå¸‚ | å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | å¤šå¼µ(å«å·²è¨»éŠ·) |
| å»ºè­°æ±ºç­– | Hold |


## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. autoimmune oophoritis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.78%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

### ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ

Insulin Lispro æ˜¯ä¸€ç¨®é€Ÿæ•ˆäººå·¥èƒ°å³¶ç´ é¡ä¼¼ç‰©ï¼Œé€éçµåˆèƒ°å³¶ç´ å—é«”ä¾†ä¿ƒé€²è‘¡è„ç³–é€²å…¥ç´°èƒï¼Œé™ä½è¡€ç³–ã€‚

èˆ‡è‡ªé«”å…ç–«æ€§åµå·¢ç‚çš„é—œè¯åˆ†æï¼š
1. **è‡ªé«”å…ç–«å¤šå…§åˆ†æ³Œç—‡å€™ç¾¤ (APS)**ï¼šç¬¬ä¸€å‹ç³–å°¿ç—…å¸¸èˆ‡å…¶ä»–è‡ªé«”å…ç–«ç–¾ç—…å…±å­˜ï¼ŒåŒ…æ‹¬è‡ªé«”å…ç–«æ€§åµå·¢ç‚
2. **èƒ°å³¶ç´ çš„å…ç–«èª¿ç¯€ä½œç”¨**ï¼šèƒ°å³¶ç´ å¯èƒ½å°å…ç–«ç³»çµ±æœ‰æŸäº›èª¿ç¯€ä½œç”¨ï¼Œä½†æ­¤æ©Ÿè½‰å°šæœªåœ¨åµå·¢è‡ªé«”å…ç–«ä¸­è¢«è­‰å¯¦
3. **é–“æ¥é—œè¯**ï¼šæ­¤é æ¸¬å¯èƒ½åæ˜ çŸ¥è­˜åœ–è­œä¸­è‡ªé«”å…ç–«ç–¾ç—…é–“çš„é—œè¯æ€§ï¼Œè€Œéç›´æ¥æ²»ç™‚æ•ˆæœ

ç›®å‰ç¼ºä¹æ©Ÿè½‰æ”¯æŒ Insulin Lispro å¯ç›´æ¥æ²»ç™‚è‡ªé«”å…ç–«æ€§åµå·¢ç‚ã€‚

### è‡¨åºŠè©¦é©—

ç›®å‰ç„¡ç›¸é—œè‡¨åºŠè©¦é©—ç™»è¨˜

### ç›¸é—œæ–‡ç»

ç›®å‰ç„¡ç›´æ¥ç›¸é—œæ–‡ç»

**æ³¨æ„**ï¼šæœ‰æ–‡ç»æ¢è¨èƒ°å³¶ç´ æ²»ç™‚ç¬¬äºŒå‹ç³–å°¿ç—…ï¼Œä½†èˆ‡è‡ªé«”å…ç–«æ€§åµå·¢ç‚ç„¡é—œã€‚

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. thiamine-responsive dysfunction syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.37%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.37%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. focal stiff limb syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.36%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.36%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. classic stiff person syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.36%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.36%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. opsismodysplasia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.34%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.34%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. drug-induced localized lipodystrophy</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.09%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.09%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. pancreatic agenesis</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.09%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.09%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. centrifugal lipodystrophy</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.04%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.04%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. pressure-induced localized lipoatrophy</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.03%</span>
</summary>
<div class="indication-content">

### TxGNN é æ¸¬è³‡è¨Š

- **é æ¸¬åˆ†æ•¸**ï¼š99.03%
- **è­‰æ“šç­‰ç´š**ï¼šL5ï¼ˆåƒ…æ¨¡å‹é æ¸¬ï¼‰

### è‡¨åºŠè­‰æ“š

<div class="no-evidence-warning">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„ç›´æ¥è‡¨åºŠè©¦é©—æˆ–æ–‡ç»è­‰æ“šã€‚æ­¤ç‚º AI æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥ç ”ç©¶é©—è­‰ã€‚
</div>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ | ç‹€æ…‹ |
|---------|------|------|-----------|------|
| è¡›ç½²èŒç–«è¼¸å­—ç¬¬000898è™Ÿ | å„ªæ³Œæ¨‚ç­†-æ··åˆå‹ 25 100å–®ä½/æ¯«å‡ | æ³¨å°„åŠ‘ | ç³–å°¿ç—… | æœ‰æ•ˆ |
| è¡›ç½²èŒç–«è¼¸å­—ç¬¬000900è™Ÿ | å„ªæ³Œæ¨‚ç­†æ³¨å°„åŠ‘ 100å–®ä½/æ¯«å‡ | æ³¨å°„åŠ‘ | ç³–å°¿ç—… | æœ‰æ•ˆ |
| è¡›éƒ¨èŒç–«è¼¸å­—ç¬¬001148è™Ÿ | é€Ÿæ³Œæ¨‚æ³¨å°„åŠ‘100å–®ä½/æ¯«å‡ | æ³¨å°„æ¶²åŠ‘ | ç³–å°¿ç—…(æˆäººã€é’å°‘å¹´ã€1æ­²ä»¥ä¸Šå…’ç«¥) | å·²è¨»éŠ· |

## å®‰å…¨æ€§è€ƒé‡

- **ä¸»è¦é¢¨éšª**ï¼šä½è¡€ç³–

- **è—¥ç‰©äº¤äº’ä½œç”¨**ï¼š
  - å½±éŸ¿è¡€ç³–çš„è—¥ç‰©ï¼ˆå¦‚ï¼šå£æœé™è¡€ç³–è—¥ã€thiazideé¡åˆ©å°¿åŠ‘ã€corticosteroidsï¼‰
  - Beta-blockers å¯èƒ½æ©è“‹ä½è¡€ç³–ç—‡ç‹€

- **ç‰¹æ®Šæ—ç¾¤**ï¼š
  - è…åŠŸèƒ½ä¸å…¨éœ€èª¿æ•´åŠ‘é‡
  - å¦Šå¨ æœŸé–“èƒ°å³¶ç´ éœ€æ±‚å¯èƒ½è®ŠåŒ–

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

<div class="dfi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**é…’ç²¾ (alcohol)** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šAlcohol may cause hypoglycemia or hyperglycemia in patients with diabetes.  Hypoglycemia most frequently occurs during acute consumption of alcohol.  Even modest amounts can lower blood sugar signific...
- å»ºè­°ï¼šPatients with diabetes should avoid consuming alcohol if their blood glucose is not well controlled, or if they have hypertriglyceridemia, neuropathy, or pancreatitis.  Patients with well controlled d...



### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a></div>

**è‚è‡Ÿç–¾ç—… (Liver Diseases)** ğŸŸ¡ Moderate
- Insulin requirements may be diminished in patients with renal or hepatic impairment due to reduced insulin metabolism and, in the latter case, also to reduced capacity for gluconeogenesis.  Lower initial dosages may be appropriate, with careful monit...

**Hypokalemia** ğŸŸ¡ Moderate
- Hypokalemia may commonly occur during treatment with insulin.  Use with caution in patients who may be particularly at risk of developing hypokalemia (e.g., patients using potassium-lowering medications, patients taking medications sensitive to serum...

**Hypoglycemia** ğŸŸ¡ Moderate
- Hypoglycemia may commonly occur during treatment with insulin and/or oral hypoglycemic agents.  Care should be taken in patients who may be particularly susceptible to the development of hypoglycemic episodes during the use of these drugs, including ...

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šHold**

**ç†ç”±ï¼š**
Insulin Lispro ç”¨æ–¼è‡ªé«”å…ç–«æ€§åµå·¢ç‚çš„é æ¸¬ç¼ºä¹æ˜ç¢ºçš„æ©Ÿè½‰æ”¯æŒå’Œè‡¨åºŠè­‰æ“šã€‚é›–ç„¶ç³–å°¿ç—…èˆ‡è‡ªé«”å…ç–«æ€§åµå·¢ç‚å¯èƒ½å…±å­˜æ–¼è‡ªé«”å…ç–«å¤šå…§åˆ†æ³Œç—‡å€™ç¾¤ä¸­ï¼Œä½†èƒ°å³¶ç´ ä¸¦éé‡å°åµå·¢è‡ªé«”å…ç–«çš„æ²»ç™‚ã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- æ¢è¨èƒ°å³¶ç´ åœ¨è‡ªé«”å…ç–«èª¿ç¯€ä¸­çš„æ½›åœ¨è§’è‰²
- åˆ†æ APS æ‚£è€…ä¸­èƒ°å³¶ç´ æ²»ç™‚èˆ‡åµå·¢åŠŸèƒ½çš„é—œè¯
- é€²è¡ŒåŸºç¤ç ”ç©¶ä»¥é©—è­‰æ©Ÿè½‰å‡èªª
- ç›®å‰æ‡‰èšç„¦æ–¼å·²å»ºç«‹çš„å…ç–«èª¿ç¯€æ²»ç™‚ç­–ç•¥


---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Theophylline]({{ "/drugs/theophylline/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Methocarbamol]({{ "/drugs/methocarbamol/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Sodium Citrate]({{ "/drugs/sodium_citrate/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Inclisiran]({{ "/drugs/inclisiran/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Metoprolol]({{ "/drugs/metoprolol/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Insulin Lisproè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/insulin_lispro/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_insulin_lispro,
  title = {Insulin Lisproè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/insulin_lispro/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
